Want to join the conversation?
$ALXN Product Update: Alexion Pharmaceuticals, Inc. announced today that Japan's Ministry of Health, Labour and Welfare approved the Company's New Drug Application for the use of Strensiq® (asfotase alfa), as a treatment for patients in Japan with hypophosphatasia (HPP), a life-threatening, ultra-rare metabolic disorder.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!